Role of Induction Therapy Surgical Resection of Non-Small Cell Lung Cancer After Induction Therapy

被引:17
|
作者
Ripley, R. Taylor [1 ]
Rusch, Valerie W. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Thorac Serv, Dept Surg, New York, NY 10065 USA
关键词
Induction therapy; Surgery; Stage III lung cancer; STAGE-IIIA N2; SUPERIOR SULCUS TUMORS; COMPARING PERIOPERATIVE CHEMOTHERAPY; TRANSBRONCHIAL NEEDLE ASPIRATION; VINORELBINE PLUS CISPLATIN; PHASE-II; RANDOMIZED-TRIAL; PREOPERATIVE CHEMOTHERAPY; NEOADJUVANT THERAPY; CONCURRENT CHEMOTHERAPY;
D O I
10.1016/j.thorsurg.2013.04.004
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Patients with Stage III non-small cell lung cancer are best managed by multimodality therapy. Patients with N2 disease can be treated with induction therapy (usually chemotherapy) followed by surgical resection. Patients whose medical comorbidities preclude surgery should be treated with definitive chemoradiotherapy. T3 or T4 tumors involving the superior sulcus or spine are best managed with induction chemoradiotherapy and surgical resection.
引用
收藏
页码:273 / +
页数:14
相关论文
共 50 条
  • [31] Induction Concurrent Chemoradiation Therapy for Invading Apical Non-Small Cell Lung Cancer
    Miyoshi S.
    Iuchi K.
    Nakamura K.
    Nakagawa K.
    Maeda H.
    Ohno K.
    Nakahara K.
    Nakano N.
    Okumura M.
    Ohta M.
    [J]. The Japanese Journal of Thoracic and Cardiovascular Surgery, 2004, 52 (3) : 120 - 126
  • [32] Non-small cell lung cancer: The role of surgery after induction chemo and/or radiotherapy
    Stamatelopoulos, A.
    Zaragkas, S.
    Sofoudis, C.
    [J]. JOURNAL OF BUON, 2010, 15 (02): : 213 - 220
  • [33] Surgical strategies in the therapy of non-small cell lung cancer
    Al-Shahrabani, Feras
    Vallboehmer, Daniel
    Angenendt, Sebastian
    Knoefel, Wolfram T.
    [J]. WORLD JOURNAL OF CLINICAL ONCOLOGY, 2014, 5 (04): : 595 - 603
  • [34] Surgical therapy of early non-small cell lung cancer
    Deslauriers, J
    Grégoire, J
    [J]. CHEST, 2000, 117 (04) : 104S - 109S
  • [35] Venous thromboembolism in non-small cell lung cancer patients who underwent surgery after induction therapy
    Kaminuma, Yasunori
    Tanahashi, Masayuki
    Suzuki, Eriko
    Yoshii, Naoko
    Niwa, Hiroshi
    [J]. GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2020, 68 (10) : 1156 - 1162
  • [36] What is the optimal local treatment after induction therapy in stage III non-small cell lung cancer?
    Grunenwald, DH
    [J]. LUNG CANCER: CURRENT TOPICS, 2001, : 229 - 231
  • [37] Venous thromboembolism in non-small cell lung cancer patients who underwent surgery after induction therapy
    Yasunori Kaminuma
    Masayuki Tanahashi
    Eriko Suzuki
    Naoko Yoshii
    Hiroshi Niwa
    [J]. General Thoracic and Cardiovascular Surgery, 2020, 68 : 1156 - 1162
  • [38] Maintenance treatment after induction therapy in non-small cell lung cancer: latest evidence and clinical implications
    Gentzler, Ryan D.
    Patel, Jyoti D.
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2014, 6 (01) : 4 - 15
  • [39] Remediastinoscopy after induction chemotherapy in non-small cell lung cancer
    Mateu-Navarro, M
    Rami-Porta, R
    Bastus-Piulats, R
    Cirera-Nogueras, L
    González-Pont, G
    [J]. ANNALS OF THORACIC SURGERY, 2000, 70 (02): : 391 - 395
  • [40] Induction therapy for non-small cell lung cancer with involved mediastinal nodes in multiple stations
    Okada, M
    Tsubota, N
    Yoshimura, M
    Miyamoto, Y
    Matsuoka, H
    [J]. CHEST, 2000, 118 (01) : 123 - 128